Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Harvey Montijo

Foot and Ankle Surgery Wellington, FL Medical Doctor

NPI 1396979480 CMS profile 1058047

10111 Forest Hill Blvd Rm 151, Wellington, FL 33414

Open in the dashboard

General payments

$24,625

129 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Harvey Montijo of Wellington, FL is reported in the CMS Open Payments database as having received $24,625 across 129 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 72nd percentile of Foot and Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,114 12
2024 General $3,004 11
2023 General $12,023 21
2022 General $2,278 18
2021 General $1,322 24
2020 General $452 11
2019 General $3,432 32

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Harvey Montijo
  • Foot and Ankle Surgery median
  • Middle half of Foot and Ankle Surgery
  • National median

In program year 2025, general payments to Harvey Montijo were reported at $2,114. Among 650 Foot and Ankle Surgery profiles paid that year, the median was $1,183 and the middle half received between $267 and $6,309.

Show as a table
Year Harvey Montijo Foot and Ankle Surgery median Middle half National median
2019 $3,432 $1,327 $279–$5,421 $163
2020 $452 $795 $121–$3,473 $114
2021 $1,322 $1,289 $201–$4,963 $132
2022 $2,278 $1,539 $270–$6,067 $149
2023 $12,023 $1,117 $257–$5,264 $160
2024 $3,004 $1,064 $235–$4,944 $164
2025 $2,114 $1,183 $267–$6,309 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Globus Medical, Inc. $15,707 24 payments
  2. In2Bones USA, LLC $2,500 1 payment
  3. Stryker Corporation $1,984 26 payments
  4. Ortho Development Corporation $1,878 2 payments
  5. Smith+Nephew, Inc. $896 33 payments
  6. Zimmer Biomet Holdings, Inc. $704 13 payments
  7. Kyocera Medical Technologies, Inc. $177 1 payment
  8. Carbofix Orthopedics Inc $122 3 payments
  9. Onkos Surgical, Inc. $88 1 payment
  10. DePuy Synthes Sales Inc. $79 3 payments
  11. Other $489 22 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $8,369 11 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,800 1 payment
  3. Food and Beverage $4,497 106 payments
  4. Travel and Lodging $4,459 10 payments
  5. Honoraria $2,500 1 payment
Products named General payments · program years 2019–2025
  1. PROVIDENCE $8,000 3 payments
  2. CoLink $2,500 1 payment
  3. Provident Hip System $1,706 4 payments
  4. Legacy Stelkast Knee $1,542 3 payments
  5. MAKO Knees, Hips $1,374 15 payments
  6. Joint Arthoplasty $785 3 payments
  7. Balanced Knee Revision System $739 1 payment
  8. Tri Taper Stem $400 1 payment
  9. Joints $400 1 payment
  10. MAKO Knees, Hips $332 4 payments
  11. Other $3,215 91 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 25 drugs

Part D claims

3,344

Median for Orthopedic Surgery: 203

Drug cost

$36,466

Median for Orthopedic Surgery: $1,433

Branded share of claims

30.9%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 712 $13,461
Celecoxib Generic 247 $3,864
Diclofenac Sodium Generic 142 $3,113
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 256 $2,348
Tramadol Hcl Generic 231 $1,570
Cephalexin Generic 215 $1,426
Gabapentin Generic 212 $1,376
Ondansetron Hcl Generic 190 $1,312
Lidocaine Generic 14 $1,210
Mupirocin Generic 179 $1,102

The 10 drugs with the highest cost, of 25 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 88 billing codes

Paid by Medicare

$208,670

Of which drugs: $18,325

Medicare patients

410

Average age 76

Services billed

8,924

261 women, 149 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 33%
Diabetes 31%
Chronic kidney disease 27%
Depression 26%
Osteoporosis 26%
Atrial fibrillation 23%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg J7322 Office 16 1,080 $14,786
Injection, methylprednisolone acetate, 1 mg J1010 Office 44 5,521 $536
Injection, methylprednisolone acetate, 80 mg J1040 Office 18 23 $146

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
EVENITY
  • Amgen Inc. $10
$10 — —
Prolia
  • Amgen Inc. $10
$10 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

129 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Foot and Ankle Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record